Holen Sie sich die Stockscreener-App
4.42
0.68%
0.03
Schlusskurs vom Vortag:
$4.39
Offen:
$4.28
24-Stunden-Volumen:
637.78K
Relative Volume:
0.76
Marktkapitalisierung:
$292.22M
Einnahmen:
$69.23M
Nettoeinkommen (Verlust:
$-33.10M
KGV:
-3.7458
EPS:
-1.18
Netto-Cashflow:
$-39.26M
1W Leistung:
-1.56%
1M Leistung:
+27.56%
6M Leistung:
+42.58%
1J Leistung:
+148.31%
1-Tages-Spanne:
$4.17
$4.435
1-Wochen-Bereich:
$4.17
$4.8204
52-Wochen-Spanne:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Vergleichen Sie STIM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.42 | 290.24M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
What are analysts’ price targets for Neuronetics Inc. in the next 12 monthsBeginner Investor Planner With High Returns - jammulinksnews.com
Neuronetics Announces Positive Real-World Findings on NeuroStar TMS for Treating Depression in Adolescents and Young Adults - Quiver Quantitative
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents - Stock Titan
AI Trend Models Suggest Bounce for Neuronetics Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Candlestick Reversal Detected on Neuronetics Inc.’s ChartWeekly Stock Opportunity Radar Scanner Activated - beatles.ru
Neuronetics Inc. Price Targets Raised After ReboundLow Risk Swing Trade Opportunities Identified - metal.it
Short Covering May Lift Neuronetics Inc. in Near TermBreakout Momentum Picks With Protection Outlined - beatles.ru
How strong is Neuronetics Inc. company’s balance sheetBuild wealth steadily with proven stock picks - jammulinksnews.com
What are Neuronetics Inc. company’s key revenue driversUnlock your portfolio’s full growth potential - jammulinksnews.com
Does Neuronetics Inc. stock perform well during market downturnsInvest confidently with real-time updates - jammulinksnews.com
Why is Neuronetics Inc. stock attracting strong analyst attentionBuild wealth steadily with expert advice - jammulinksnews.com
Is Neuronetics Inc. stock overvalued or undervaluedMaximize portfolio growth with expert advice - jammulinksnews.com
JMP reiterates Market Outperform rating on Neuronetics stock ahead of Q2 earnings - Investing.com Canada
When is Neuronetics Inc. stock expected to show significant growthRapid growth trajectories - jammulinksnews.com
What markets is HUBCZ expanding into Is Neuronetics Inc. stock a good long term investment optionAchieve breakthrough profits with expert advice - jammulinksnews.com
Intrinsic Value of Neuronetics Inc. Stock: Is It Undervalued or OvervaluedFree Access to Community - metal.it
How many analysts rate Neuronetics Inc. as a “Buy”Extraordinary market timing - jammulinksnews.com
What analysts say about Neuronetics Inc. stockHigh-octane investment gains - PrintWeekIndia
Neuronetics Inc. Stock Analysis and ForecastSuperior portfolio returns - PrintWeekIndia
What drives Neuronetics Inc. stock priceUnprecedented profit potential - PrintWeekIndia
When is the best time to buy Neuronetics Inc. stockDynamic capital growth - jammulinksnews.com
Is Neuronetics Inc. a good long term investmentExplosive capital appreciation - Autocar Professional
Neuronetics, Inc. (NASDAQ:STIM) Soars 29% But It's A Story Of Risk Vs Reward - 富途牛牛
Neuronetics to Announce Q2 2025 Results on August 5th - MSN
Neuronetics' (NASDAQ:STIM) growing losses don't faze investors as the stock hikes 13% this past week - simplywall.st
Unexpected Trends Reshaping the Transcranial Magnetic - openPR.com
Transcranial Magnetic Stimulation (TMS) Treatment Devices Market to Reach USD 2.61 Billion by 2034 - openPR.com
Neuronetics to Report Second Quarter 2025 Financial and Operatin - GuruFocus
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Neuronetics Sets Q2 2025 Earnings Date: Leading Neurohealth Tech Company to Share Latest Financial Results - Stock Titan
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):